A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate

ClinicalTrials.gov ID: NCT00100555

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00100555. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:30 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to study the clinical safety, tolerability, and efficacy of zoledronic acid compared to an oral bisphosphonate in postmenopausal women with osteoporosis.

Study identification

NCT ID: NCT00100555
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Novartis Pharmaceuticals; Industry
Enrollment: 120 participants

Conditions and interventions

Conditions

Osteoporosis

Interventions

zoledronic acid Drug

Drug

Eligibility (public fields only)

Age range: 45 Years to 79 Years
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 2004 (Type not available)
Primary completion: Jun 2005 (Actual)
Completion: Jun 2005 (Actual)
Last update posted: Apr 27, 2012

2004 – 2005

United States locations

U.S. sites: 18
U.S. states: 16
U.S. cities: 18

Facility	City	State	ZIP	Site status
Univ. of Alabama/Division of Clinical Immunology and Rheumatology	Birmingham	Alabama	35294	—
Radiant Research	San Diego	California	92108	—
Denver Arthritis Clinic	Denver	Colorado	80230	—
Florida Medical Research Institute	Gainesville	Florida	32605	—
Northwestern Center for Clinical Research	Chicago	Illinois	60611	—
The Center for Rheumatology and Bone Research	Wheaton	Maryland	20902	—
Midwest Arthritis Center	Kalamazoo	Michigan	49048-1634	—
St. John's Medical Research	Springfield	Missouri	65807	—
Deaconess Billings Clinic Research Division	Billings	Montana	59101	—
UMDNJ-Robert Wood Johnson Medical School	New Brunswick	New Jersey	08903	—
Helen Hayes Hospital - Regional Bone Clinic	West Haverstraw	New York	10993	—
Private Practice	Mayfield Village	Ohio	44143	—
The Arthritis Clinic of Jackson	Jackson	Tennessee	38305	—
Radiant Research	Dallas	Texas	75235	—
Univ. of North Texas Health Science Center at Fort Worth	Fort Worth	Texas	76107	—
St. Luke's Episcopal Hospital Ctr for Ortho. Res. and Education	Houston	Texas	77030	—
Women's Health Center	Salt Lake City	Utah	84117	—
Valley Medical Associates	Lewisburg	West Virginia	24901	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00100555, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 27, 2012 · Synced Nov 15, 2026